Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (31-40 of 485) with videos related to

Pageof 49
Sort By:
Pharmacoeconomics|September 22, 2005
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos, Maarten J Postma, Lieven Annemans
Human Fertility (Cambridge, England)|November 12, 2009
Economics of assisted reproduction: access to fertility treatments and valuing live births in economic termsMark P Connolly, William Ledger, Maarten J Postma
Expert Review of Clinical Pharmacology|January 1, 2013
Accumulating evidence for the case of differential discountingMaarten J Postma, Mehraj Parouty, Tjalke A Westra
Vaccine|September 12, 2009
Conclusions on (cost-)effectiveness of pertussis booster vaccination strategies highly dependent on selections made in evidence reviewMaarten J Postma, Robin de Vries, John Roord
Human Vaccines & Immunotherapeutics|November 27, 2014
Cost-effectiveness of hepatitis A vaccination in IndonesiaAuliya A Suwantika, Philippe Beutels, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in AnticoagulationJelena Stevanović, Maarten J Postma, Hoa H Le
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2007
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuriaMaarten J Postma, Cornelis Boersma, Ron T Gansevoort
Vaccine|March 6, 2022
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in EthiopiaAbrham Wondimu, Maarten J Postma, Marinus van Hulst
Expert Review of Vaccines|August 8, 2020
The potential impact of COVID-19 pandemic on the immunization performance in IndonesiaAuliya A Suwantika, Cornelis Boersma, Maarten J Postma
Cost Effectiveness and Resource Allocation : C/E|January 24, 2014
Budget constraint and vaccine dosing: a mathematical modelling exerciseBaudouin A Standaert, Desmond Curran, Maarten J Postma
Pageof 49

Showing results (31-40 of 485) with videos related to

Sort By:
Pageof 49
Pharmacoeconomics|September 22, 2005
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos, Maarten J Postma, Lieven Annemans
Human Fertility (Cambridge, England)|November 12, 2009
Economics of assisted reproduction: access to fertility treatments and valuing live births in economic termsMark P Connolly, William Ledger, Maarten J Postma
Expert Review of Clinical Pharmacology|January 1, 2013
Accumulating evidence for the case of differential discountingMaarten J Postma, Mehraj Parouty, Tjalke A Westra
Vaccine|September 12, 2009
Conclusions on (cost-)effectiveness of pertussis booster vaccination strategies highly dependent on selections made in evidence reviewMaarten J Postma, Robin de Vries, John Roord
Human Vaccines & Immunotherapeutics|November 27, 2014
Cost-effectiveness of hepatitis A vaccination in IndonesiaAuliya A Suwantika, Philippe Beutels, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in AnticoagulationJelena Stevanović, Maarten J Postma, Hoa H Le
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2007
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuriaMaarten J Postma, Cornelis Boersma, Ron T Gansevoort
Vaccine|March 6, 2022
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in EthiopiaAbrham Wondimu, Maarten J Postma, Marinus van Hulst
Expert Review of Vaccines|August 8, 2020
The potential impact of COVID-19 pandemic on the immunization performance in IndonesiaAuliya A Suwantika, Cornelis Boersma, Maarten J Postma
Cost Effectiveness and Resource Allocation : C/E|January 24, 2014
Budget constraint and vaccine dosing: a mathematical modelling exerciseBaudouin A Standaert, Desmond Curran, Maarten J Postma
Pageof 49